Kynam Capital Management, LP
CIK 1907884 · Holdings on Dec 31, 2023 · First reported Feb 14, 2024
Top ten holdings
Q4 2023- NTRA17.01%
- SNDX13.84%
- CLDX13.49%
- PCVX7.12%
- VERA6.35%
- PTGX5.20%
- IMGN4.77%
- 6177602024.74%
- COGT3.90%
- LQDA3.67%
Share classes counted separately80.09%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- SNDXWeight increased · +5.15 pp8.69% → 13.84%Shares +2.06M (+57.22%)
- NTRAWeight decreased · -5.08 pp22.09% → 17.01%Shares -603.67K (-20.10%)
- PCVXWeight decreased · -3.92 pp11.04% → 7.12%Shares -300.00K (-23.03%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 23
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | NTRANATERA INC View history and evidence | $150.34M | 17.01% | 2.40M shares | 22.09% → 17.01%-5.08 pp -603.67K (-20.10%) | Reduced | ↗▾ |
| 02 | SNDXSYNDAX PHARMACEUTICALS INC View history and evidence | $122.31M | 13.84% | 5.66M shares | 8.69% → 13.84%+5.15 pp +2.06M (+57.22%) | Added | ↗▾ |
| 03 | CLDXCELLDEX THERAPEUTICS INCCOM NEW View history and evidence | $119.21M | 13.49% | 3.01M shares | 14.64% → 13.49%-1.15 pp -194.10K (-6.07%) | Reduced | ↗▾ |
| 04 | PCVXVAXCYTE INC View history and evidence | $62.95M | 7.12% | 1.00M shares | 11.04% → 7.12%-3.92 pp -300.00K (-23.03%) | Reduced | ↗▾ |
| 05 | VERAVERA THERAPEUTICS INCCL A View history and evidence | $56.14M | 6.35% | 3.65M shares | 6.74% → 6.35%-0.39 pp +694.29K (+23.49%) | Added | ↗▾ |
| 06 | PTGXPROTAGONIST THERAPEUTICS INC View history and evidence | $45.97M | 5.20% | 2.00M shares | 5.04% → 5.20%+0.16 pp +186.22K (+10.24%) | Added | ↗▾ |
| 07 | IMGNIMMUNOGEN INC View history and evidence | $42.18M | 4.77% | 1.42M shares | Prior unavailable +1.42M | New | ↗▾ |
| 08 | 617760202MORPHOSYS AG ADRSPONSORED ADS View history and evidence | $41.92M | 4.74% | 4.23M shares | Prior unavailable +4.23M | New | ↗▾ |
| 09 | COGTCOGENT BIOSCIENCES INC View history and evidence | $34.43M | 3.90% | 5.85M shares | 3.58% → 3.90%+0.32 pp +3.64M (+164.91%) | Added | ↗▾ |
| 10 | LQDALIQUIDIA CORPCOM NEW View history and evidence | $32.46M | 3.67% | 2.70M shares | 2.11% → 3.67%+1.56 pp +698.32K (+34.92%) | Added | ↗▾ |
Options overlay 1
$19.03M notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
CORTCORCEPT THERAPEUTICS INC View history and evidence | Put | 585.90K | $19.03M | +585.90K | ▾ |
1 / 1 options · preview only
Exited positions 10
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| TSHA TAYSHA GENE THERAPIES INC | Non-derivative | -3,281,313 | -$10.37M | SEC filing ↗ | SEC filing ↗ |
| SNDX SYNDAX PHARMACEUTICALS INC | Call | -400,000 | -$5.81M | SEC filing ↗ | SEC filing ↗ |
| IMVT IMMUNOVANT INC | Put | -100,000 | -$3.84M | SEC filing ↗ | SEC filing ↗ |
3 / 10 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1907884 · Period 2023-12-31
Data loaded 2026-09-23 · First reported 2024-02-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 902614125
}Take these holdings further.
This page includes 24 of 24 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 24 of 24 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1907884","quarter":"2023Q4","page_size":100}
get_institutional_manager_history
{"cik":"1907884","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.